PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PT Kalbe Farma Price: 0.0926 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 0.0926 | 0.0926 | 0.0926 | 0.0926 | 1277.00 |
May 02, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
May 01, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 30, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 29, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 26, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 25, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 24, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 23, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 22, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 19, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 18, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 17, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 16, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 15, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 12, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 11, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 10, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 09, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 08, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 05, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 04, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 03, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 02, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Apr 01, 2024 | 0.09 | 0.09 | 0.09 | 0.09 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.0125
Minimum
Mar 26 2020
0.17
Maximum
Dec 30 2022
0.1089
Average
0.1055
Median
Feb 24 2021
Price Benchmarks
Taihe Group Inc | 3.30 |
CEL-SCI Corp | 1.63 |
AIM ImmunoTech Inc | 0.4048 |
IGC Pharma Inc | 0.5112 |
NovaBay Pharmaceuticals Inc | 0.0949 |
Price Related Metrics
PE Ratio | 23.71 |
PS Ratio | 2.154 |
Price to Book Value | 3.125 |
Earnings Yield | 4.22% |
Market Cap | 4.283B |
Operating PE Ratio | 18.11 |
Normalized PE Ratio | 23.84 |